Technical notes

EXPLORE OUR SCIENTIFIC RESOURCES

Contact an expert

Published on the 12 March 2025

Technical Note: High-content imaging of brain-on-chip microfluidic devices using PreciScan intelligent acquisition.

Brain-on-chips (BoC) are innovative tools that simulate complex brain environments, enhancing our understanding of neurodegenerative diseases (NDDs). While a range of BoC platforms have been developed…
Published on the 17 May 2022

Preclinical models of cerebral haemorrhage

Haemorrhagic strokes account for 10-15% of all strokes. In 40% of patients, haemorrhagic strokes are fatal within one month, rising to 54% after 1 year. Haemorrhagic strokes have a devastating effect …
Published on the 22 September 2021

Newsletter #11: World Alzheimer’s Day: review of the ETAP-Lab preclinical models

We'd like to take the opportunity, on World Alzheimer's Day, to revisit the models ETAP-Lab makes available to the scientific community for use in the search for new therapies to fight this disease. …
Published on the 14 September 2021

Newsletter #10 – New preclinical model of pruritus and update to our other atopic dermatitis models

Atopic dermatitis is a skin condition affecting 4% of the population worldwide. It affects all age groups, regardless of sex. Over the past 30 years, the number of diagnosed cases in industrialised co…
Published on the 21 May 2021

Newsletter #9 : ETAP-Lab launches its new model, associating beta-amyloid oligomers and aged mice

In May 2021, ETAP-Lab is adding its latest mouse model of Alzheimer’s disease to its catalogue. Using our expertise in the manufacture of oligomers from A-beta1-42 peptide, we have demonstr…
Published on the 1 March 2021

Newsletter #7: From bench to bed side: how the new preclinical stroke models change the game.

Strokes are the second most common cause of mortality in the over-60s and the leading cause of acquired disability. There are currently only two approved treatments for the management of patients affe…
Published on the 21 January 2021

Newsletter #8: The ETAP-Lab Psoriasis Model

The psoriasis model induced by the chronic application of imiquimod (IMI) proposed by ETAP-Lab reproducibly replicates the key markers of the pathology observed in humans: hyperproliferation of kerati…
Published on the 27 November 2020

New hope for Alzheimer’s disease: what’s combining therapeutic strategies all about?

Evidence from various studies indicates that Alzheimer’s Disease (AD) develops as a result of interaction between multiple complex and overlapping pathophysiological pathways, suggesting that a pharma…